Venrock Healthcare Capital Partners XP, L.P. — SEC insider filings

SEC reporting owner CIK 2037157. 4 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2026-10-22 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Lycia Therapeutics, Inc. (LYCA)10% owner412 legs · 2,078,749 sh · $38,522,394—3

Insider filings — Venrock Healthcare Capital Partners XP, L.P.

FiledFormIssuerReported transactionsSource
2026-11-044Lycia Therapeutics, Inc. (LYCA)
jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, VHCP Management XP, LLC, Koh Bong Y, Shah Nimish P
Purchase (P): 8,305 @ $26.95EDGAR
2026-10-304Lycia Therapeutics, Inc. (LYCA)
jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, VHCP Management XP, LLC, Koh Bong Y, Shah Nimish P
Purchase (P): 10,570 @ $25.23 · Purchase (P): 4,430 @ $25.97 · Purchase (P): 1,000 @ $26.33 · Purchase (P): 8,804 @ $26.27 · Purchase (P): 200 @ $26.86EDGAR
2026-10-274Lycia Therapeutics, Inc. (LYCA)
jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, VHCP Management XP, LLC, Koh Bong Y, Shah Nimish P
Purchase (P): 24,560 @ $25.68 · Purchase (P): 28,379 @ $26.11 · Conversion (C): 4,779,793 · Purchase (P): 1,944,444 @ $18 · Purchase (P): 8,261 @ $26.97 · Purchase (P): 8,729 @ $25.84 · +3 moreEDGAR
2026-10-223Lycia Therapeutics, Inc. (LYCA)
jointly with Venrock Healthcare Capital Partners III, L.P., VHCP Co-Investment Holdings III, LLC, VHCP Management III, LLC, Venrock Healthcare Capital Partners EG, L.P., VHCP Management EG, LLC, VHCP Management XP, LLC, Koh Bong Y, Shah Nimish P
Holdings only — no transactions reportedEDGAR

FilingPulse's Form 4 archive currently extends back to 2021-04-29 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2037157 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs